SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000913275-99-000023
Filing Date
1999-11-12
Accepted
1999-11-12 00:00:00
Documents
3
Period of Report
1999-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR PERIOD ENDED SEPTEMBER 30, 1999 0000913275-99-000023-d1.html 10-Q 38862
2 EMPLOYMENT AGREEMENT 0000913275-99-000023-d2.html EX-10.13 26801
3 FINANCIAL DATA SCHEDULE EX-27.1 2583
  Complete submission text file 0000913275-99-000023.txt   69885
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22570 | Film No.: 99747377
SIC: 2833 Medicinal Chemicals & Botanical Products